NOV Inc. vs Exxon Mobil Corporation — Stock Comparison
Q·Score Breakdown
4.9
Bearish
Overall
6.4
Neutral
Quality
Health
Growth
Valuation
Sentiment
NOV
Clean balance sheet with low leverage (0.4× debt-to-equity).
⚠ revenue declining 2% year-over-year.
XOM
Clean balance sheet with low leverage (0.2× debt-to-equity).
⚠ earnings contracting 43% year-over-year.
Analyst Consensus
HOLD
Target $21.10 (+6.2%)
20 analysts
HOLD
Target $165.50 (+8.3%)
22 analysts
Fundamentals
NOV
XOM
79.4×
Trailing P/E
25.7×
14.8×
Forward P/E
15.0×
1.0%
Profit Margin
7.8%
20.6%
Gross Margin
29.8%
1.5%
ROE
9.9%
-2.4%
Revenue Growth
2.6%
-73.7%
Earnings Growth
-43.4%
0.94
Beta
0.29
—
Price / Book
—
$7.1B
Market Cap
$634.9B
$12 – $21
52-Week Range
$101 – $176
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →